Stockholders' Deficit (Details Textual) - USD ($) |
1 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Apr. 29, 2020 |
Jul. 29, 2019 |
Jul. 23, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2016 |
|
| Preferred stock, par value | $ 0.00001 | $ 0.00001 | |||||
| Preferred stock, authorized | 15,000,000 | 15,000,000 | |||||
| Shares per shares | $ 7.14 | ||||||
| Common stock authorized | 50,000,000 | 50,000,000 | |||||
| Common stock par value | $ 0.00001 | $ 0.00001 | |||||
| Shares based compensation | $ 3,303,211 | $ 1,988,626 | |||||
| Legal services value | 610,550 | ||||||
| Stock option expense | $ 308,573 | 1,047,686 | |||||
| Stock-based compensation expense for unvested stock options | 11,402 | ||||||
| Stock-based compensation expense weighted average period term | 4 months 24 days | ||||||
| Stock option, description | The Compensation Committee of the Board of Directors approved an exchange (the “Exchange”) of grants under the HyreCar Inc. 2018 Equity Incentive Plan (the “2018 Plan”) previously made to executive officers and directors of the Company (the “Grantees”). Pursuant to the Exchange, the Grantees agreed to the cancellation of options to purchase an aggregate of 1,487,500 shares of the Company’s common stock under the 2018 Plan in exchange for the issuance of an aggregate of 822,500 shares of fully vested restricted stock under the 2018 Plan. | The weighted average grant-date fair value per share of options for the year ended December 31, 2019 was $1.85 and the 2019 options granted had vest terms from two to four years. The total intrinsic value of options exercised during the years ended December 31, 2020 and 2019 was $210,055 and $106,407 respectively. The total fair value of options vested for the years ended December 31, 2020 and 2019 was $83,774 and $468,236, respectively. | |||||
| Acquisition of stock, description | The 2018 Plan provides for the grant of equity awards to purchase shares of common stock. Up to 3,000,000 shares of common stock may be issued pursuant to awards granted under the 2018 Plan, subject to increases that occur starting in 2021. The 2018 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board. | The 2016 Plan provides for the grant of equity awards to highly qualified personnel, including stock options, restricted stock, stock appreciation rights, and restricted stock units to purchase shares of common stock. Up to 2,227,777 shares of common stock may be issued pursuant to awards granted under the 2016 Plan. The 2016 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board. | |||||
| Warrants exercised - cashless Share | 15,000 | ||||||
| Warrants exercised for cash | $ 873,403 | ||||||
| Restricted stock | 794,325 | 341,000 | |||||
| Additional expense related to stock based compensation | $ 1,434,132 | ||||||
| Unrecognized compensation expense | $ 3,120,329 | ||||||
| Unrecognized compensation expense period | 2 years 7 months 6 days | ||||||
| Initial Public Offering [Member] | |||||||
| Common stock issued and sold | 4,025,000 | 4,025,000 | |||||
| Common stock, per share | $ 3.00 | $ 3.00 | |||||
| Underwriters gross proceeds | $ 12,075,000 | $ 12,075,000 | |||||
| Underwriters’ discounts and commissions | 603,750 | 603,750 | |||||
| Underwriters net proceeds | 11,321,250 | 11,321,250 | |||||
| Underwriters deducting offering costs | 263,873 | 263,873 | |||||
| Reimbursable expense | $ 150,000 | $ 150,000 | |||||
| Legal and Consulting Services [Member] | |||||||
| Stock issued services | 314,535 | 135,000 | |||||
| Legal services value | $ 255,717 | $ 607,550 | |||||
| Founder [Member] | |||||||
| Stock issued services | 78,431 | ||||||
| Legal services value | $ 213,332 | ||||||
| Restricted Stock Units (RSUs) [Member] | |||||||
| Number of shares, granted | 606,500 | ||||||
| Stock-based compensation | $ 1,070,936 | 330,390 | |||||
| Non- vested granted forfeitable shares | 109,650 | ||||||
| Total fair market value vested | $ 1,036,070 | $ 160,180 | |||||
| Weighted-average grant date fair value | $ 5.94 | $ 4.44 | |||||
| Warrant [Member] | |||||||
| Number of shares, granted | |||||||
| Warrants exercised - cashless Share | 2,612 | ||||||
| Stock Options [Member] | |||||||
| Number of shares, granted | |||||||
| Stock-based compensation expense | $ 1,742,705 | $ 1,047,686 | |||||